The infection control supplies market size is expected to reach US$ 4,382.41 million by 2030 from US$ 3,323.00 million in 2022. The market is estimated to grow at a CAGR of 3.4% from 2022 to 2030.
Market Insights and Analyst View:
The infection control supply market encompasses a wide range of products and equipment designed to prevent and control the spread of infection in various settings, including healthcare facilities, laboratories, and public spaces. The prevalence of hospital-acquired infections remains a significant concern in healthcare settings. As a result, there is a growing demand for infection control supplies such as disinfectants, hand sanitizers, and personal protective equipment to reduce the risk of infections among patients and healthcare workers. Expanding healthcare infrastructure and increased healthcare spending globally have increased the demand for infection control supplies to ensure patient safety and hygiene. Growing healthcare infrastructure and increasing focus on infection prevention in emerging markets create new opportunities for infection control supply manufacturers. Rise in the number of surgical procedures that require high-intensity infection prevention & control, a surge in the number of government awareness programs to ensure a high degree of infection prevention, a rise in the geriatric population, and a surge in cases of chronic diseases such as obesity, diabetes, cancer, and respiratory disorders are the factors that are expected to drive the growth of the market.
Growth Drivers and Challenges:
Healthcare facilities in various countries such as India, Bangladesh and Japan pose a risk of infection to patients. Every year, in hospitals, infections causes unnecessary suffering and the death of millions of patients. Risks for emerging infectious diseases in the Asia Pacific are complex and believed to involve socioeconomic, environmental, and technological processes promoting the dynamics of microbial transmission. According to the National Institutes of Health, in Asia-Pacific the risk of hospital-acquired infections (HAIs) is 2–20 times higher as compared in developed countries, with ~25% of hospitalized patients reporting infections. According to the Centers for Disease Control and Prevention (CDC) in US, ~1 in 31 patients in hospitals suffers from hospital-acquired infection. Furthermore, according to the data provided by PatientCareLink, in American Hospitals alone, hospital-acquired infections account for an 1.7 million infection cases and 99,000 associated diseases yearly.
Healthcare facilities in low and middle-income countries have extremely high hospital-acquired infections rates, due to the additional challenges in achieving effective infection control, absence of cleanliness in hospitals, and lack of awareness regarding infection control. Seriously ill patients are more susceptible to infections in industrialized and developing countries. Increase in HAI cases has drove the need for preoperative infection prevention devices, thereby driving the infection control supplies market growth.
Strategic Insights
Report Segmentation and Scope:
The global infection control supplies market is segmented based on type and end user. Based on the type, the market is segmented into sterilization equipment, cleaning and disinfection equipment, disposable safety products, and others. By disposable safety products, the infection control supplies market is further segmented into gloves & goggles, covers & closures, face masks, surgical drapes and gowns, and others. The sterilization equipment segment is anticipated to register the highest CAGR during 2022–2030. Based on end users, the infection control supplies market is segmented into healthcare facilities, medical device & pharmaceutical companies, laboratories, and others. The healthcare facilities segment held the largest market share in 2022, and the same segment is expected to register the highest CAGR during the forecast period (2022–2030). The infection control supplies market, based on geography, is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, the U.K., Russia, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Segmental Analysis:
Based on type, the infection control supplies market is segmented into sterilization equipment, cleaning and disinfection equipment, disposable safety products, and others. The sterilization equipment segment is further segmented into heat sterilization equipment, radiation sterilization equipment, filtration sterilization equipment, consumables & accessories. The infection control supplies market, by disposable safety products, is further segmented into gloves & goggles, covers & closures, face masks, surgical drapes and gowns, and others. The sterilization equipment segment is anticipated to register the highest CAGR during 2022–2030. Sterilization equipment is essential in various industries, particularly healthcare and laboratory settings, to ensure that instruments, equipment, and materials are free from microorganisms such as bacteria, viruses, and fungi. The growth of sterilization equipment is driven by several factors, reflecting its crucial role in various industries, including healthcare, pharmaceuticals, laboratory, and food production. The demand for healthcare services continues to rise globally, leading to a higher need for sterilization equipment to ensure the safety of medical instruments, equipment, and devices. Awareness of the importance of infection control and prevention of healthcare-associated infections is increasing. This drives the adoption of advanced sterilization methods and equipment in healthcare settings. The Pharmaceutical industry relies on sterilization to maintain product quality and safety. As this industry expands, so does the demand for sterilization equipment to ensure the stability of pharmaceutical products and production environments. Technological advancement in sterilization methods and equipment includes developing faster, more efficient, and environmentally friendly systems, encouraging adoption, and replacing older equipment. For instance, Nanosonics launched Nanosonics AuditPro, a new digital product platform offering traceability, reporting, and workflow compliance, at the annual Association for Professionals in Infection Control and Epidemiology (APIC) virtual conference. Introducing Nanosonics AuditPro will offer infection preventionists and Quality managers an opportunity to improve and standardize infection control compliance across a broad range of medical instruments to support the management of healthcare-associated infection (HAI) risk. Based on end users, the infection control supplies market is segmented into healthcare facilities, medical device & pharmaceutical companies, laboratories, and others. The healthcare facilities segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during the forecast period (2022–2030).
The infection control supplies market, by type, is segmented into sterilization equipment, cleaning and disinfection equipment, disposable safety products, and others. The sterilization equipment segment held the largest market share in 2022, which is anticipated to register a higher CAGR during 2022–2030.
Regional Analysis:
Based on geography, the infection control supplies market is categorized into five key regions: North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The market in North America has been analyzed with a prime focus on three major countries—the US, Canada, and Mexico. The U.S. held the largest share of the North America infection control supplies market 2022. It is estimated to hold North America's largest share of the infection control supplies market during the forecast period, owing to the growing prevalence of hospital-acquired infections, high spending on research and development, product approvals by the U.S. Food and Drug Administration (FDA), and technological advances. Several factors have driven the U.S.'s rising demand for infection control supplies. Hospitals and healthcare facilities require constant suppliers of infection control supplies to maintain a clean and safe for patients and healthcare workers. This includes disinfectant, sanitizer, disposable gowns, and respiratory protection equipment. HAIs are an increasingly significant problem in hospitals and healthcare facilities, putting additional pressure on the healthcare system, facility staff, and patients. Infection prevention equipment reduces the transmission of infectious diseases when other measures, such as engineering controls and labor practices, cannot eliminate exposure. Federal, state, and local governments implemented various initiatives to combat the spread of COVID-19. During the COVID-19, the number of hospital admissions was on the rise. Regarding the total annual cost spent on these infections by healthcare facilities, SSIs are the largest contributor in the U.S. The most common types of HAIs cost around US$ 9.8 billion annually in the U.S. These efforts often included distributing infection control supplies to needy communities.
Furthermore, according to the Australasian College for Infection Prevention and Control, approximately 165,000 hospital-acquired infections (HAIs) were diagnosed in private and public hospitals in Australia in 2018, considered one of the most common complications in hospitalized patients. HAI also contributes to a significant increase in the morbidity and mortality rate and an exponentially increasing risk of readmission within 12 months. According to the same study, HAIs also often result in prolonged hospital stays, averaging 18.1 days longer than patients without these hospital-acquired complications. The national average cost per approved overnight stay is USD 2074. The consequence of the more extended hospital stays with HAI can, therefore, is associated with additional charges of 37,539 USD. HAI rates can be reduced significantly by implementing infection control procedures and equipment such as hygiene washers and disposable slings. Thus, the market is expected to grow during the forecasted period due to the increasing HAIs.
Competitive Landscape and Key Companies:
Infection control supplies market developments have been characterized as organic and inorganic growth strategies. Various companies focus on organic growth strategies such as product launches, expansion, enhancement, and relocation. Inorganic growth strategies in the market are mergers and acquisitions, partnerships, and collaborations. These activities have paved the way for the expansion of businesses, and customer base of infection control supplies market players.
- In August 2021, Ecolab Inc. opened the Ecolab Healthcare Advanced Design Center in Eagan, Minn. The state-of-the-art, 22,000-square-foot innovation center will enable Ecolab Healthcare to partner with medical device industry customers on infection prevention solutions for their cutting-edge surgical equipment and develop new solutions for hospitals and surgery centers. Custom-designed sterile barriers and equipment drapes help hospitals and surgery centers boost infection prevention measures, improve patient outcomes, and manage operational costs and efficiencies.
- In January 2022, UVD Robots Collaborated with Ecolab to Fight Hospital-Acquired Infections Globally to distribute its UV-C systems worldwide.
- In August 2021, Advanced Sterilization Products Launched the Fastest Biological Indicator for Hydrogen Peroxide Sterilization in Asia Pacific.
- In June 2023, STERIS plc announced that the Company signed an agreement to purchase the surgical instrumentation, laparoscopic instrumentation, and sterilization container assets from Becton, Dickinson, and Company for $540 million.
- In January 2021, STERIS plc signed a definitive agreement to acquire Cantel through a U.S. subsidiary. Under the terms of the agreement, STERIS acquired Cantel in a cash and stock transaction valued at $84.66 per Cantel common share, based on STERIS’s closing share price of $200.46.
- In May 2022, Getinge launched superfast indicators to ensure patient safety further. Getinge Assured Superfast 20 Biological Indicator speeds up the ability of the Central Sterile Supply Department (CSSD) to release loads safely, ensuring that the sterile instruments can be in the right place at the right time.
Company Profiles
- Advanced Sterilization Products
- Systec GMBH
- Ecolab
- Belimed
- STERUS Corporation
- Cardinal Health
- Getinge AB
- Matachana Group
- Contec Healthcare
- Pal International
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Infection Control Supplies Market Report Analysis
-
CAGR (2023 - 2031)3.40% -
Market Size 2023
US$ 3.44 Billion -
Market Size 2031
US$ 4.49 Billion
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Advanced Sterilization Products
- Systec GMBH
- Ecolab
- Belimed
- STERUS Corporation
- Cardinal Health
- Getinge AB
- Matachana Group
- Contec Healthcare
- Pal International
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Type
- Sterilization Equipment
- Cleaning and disinfection Equipment
- Disposable Safety Products
- Others and End User
By Geography
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South and Central America
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Infection Control Supplies Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 3.44 Billion |
| Market Size by 2031 | US$ 4.49 Billion |
| Global CAGR (2023 - 2031) | 3.40% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
- Advanced Sterilization Products
- Systec GMBH
- Ecolab
- Belimed
- STERUS Corporation
- Cardinal Health
- Getinge AB
- Matachana Group
- Contec Healthcare
- Pal International
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Infection Control Supplies Market
Apr 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Apr 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)